HFSA 2026 Preview: Key Heart Failure Treatment Trends And Pipeline
HFSA 2026 at a glance At HFSA 2026, the question is where competition in heart…
Respiratory Strategic Roundup: Earlier Intervention | Sep 4–Oct 7, 2026
How are emerging therapies, patient segmentation and evolving prevention…
Cell and Gene Therapy Strategic Roundup | Sep 1 – Oct 6, 2026
Gene and cell therapy competition is shifting beyond efficacy. Durability,…
Strategy Wargaming: What FDA's Volixibat Signal Means for Ipsen
Produced with LucidWargames, part of the LucidQuest ecosystem. AI-enabled…
Obesity Strategic Roundup: Beyond GLP-1 Efficacy | Sep 1 – Oct 4 , 2026
How are next-generation obesity therapies reshaping competition in the GLP-1…
CPHI 2026 Preview: Key Pharma Industry Trends to Watch
CPHI 2026 at a Glance Get ready for CPHI 2026. LucidQuest’s CPHI 2026 preview…
EURETINA 2026 Preview: Key Retinal Therapy Trends and Competitive Developments
Euretina 2026 at a glance At EURETINA 2026, retinal competition is increasingly…
Neuroscience Strategic Roundup: From Efficacy to Differentiation | Aug 25–Sept 29, 2026
Current neuroscience trends point to a broader competitive shift, as treatment…
Cardiovascular Strategic Roundup: Beyond Device Innovation | Aug 27 – Sept 30, 2026
Cardiovascular intervention is entering a new competitive phase, as…
EADV 2026 Preview: Emerging Dermatology Therapies and Competitive Trends
EADV 2026 at a glance At 2026,will differentiation in dermatology move beyond…
Endocrinology Strategic Roundup: Beyond Glycemic Control | Aug 25 – Sept 28, 2026
Endocrinology Current Trends: For pharma teams, the competitive question is…
EASD 2026 Preview: Emerging Diabetes Therapies and Competitive Trends
EASD 2026 at a gance At EASD 2026, where will competition in diabetes and…